silverjet2
Patent protection and elimination of peer competition contribute to Amarin's value as it awaits FDA approval; up 2.4% to 12.00, Long $AMRN
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.